Clinical trials
Phase 2 Heart Failure trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
378 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 5 |
| 2003 | 10 |
| 2004 | 19 |
| 2005 | 9 |
| 2006 | 10 |
| 2007 | 11 |
| 2008 | 12 |
| 2009 | 20 |
| 2010 | 26 |
| 2011 | 13 |
| 2012 | 12 |
| 2013 | 19 |
| 2014 | 13 |
| 2015 | 9 |
| 2016 | 19 |
| 2017 | 21 |
| 2018 | 14 |
| 2019 | 12 |
| 2020 | 13 |
| 2021 | 15 |
| 2022 | 16 |
| 2023 | 15 |
| 2024 | 21 |
| 2025 | 22 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 221 |
| Terminated | 52 |
| Unknown status | 34 |
| Recruiting | 33 |
| Withdrawn | 19 |
| Not yet recruiting | 9 |
| Active, not recruiting | 7 |
| Enrolling by invitation | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 15 |
| Novartis Pharmaceuticals | 9 |
| Cytokinetics | 8 |
| AstraZeneca | 7 |
| Bristol-Myers Squibb | 7 |
| Duke University | 7 |
| University of Aarhus | 7 |
| Virginia Commonwealth University | 6 |
| Cardurion Pharmaceuticals, Inc. | 5 |
| National Heart, Lung, and Blood Institute (NHLBI) | 5 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 378 |
| Cardiovascular Diseases | 21 |
| Inflammation | 12 |
| Cardiomyopathies | 11 |
| Diabetes Mellitus | 11 |
| Heart Diseases | 11 |
| Heart Failure, Diastolic | 11 |
| Myocardial Infarction | 11 |
| Renal Insufficiency | 11 |
| Cardiomyopathy, Dilated | 10 |
Trials
Showing 1 to 25 of 378. Each trial links to its page on Pharma Observatory.
278 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.